Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity Algorae Pharmaceuticals Ltd ABN/ARBN Financial year ended: 14 104 028 042 30 June...
Appendix 4G and Corporate Governance Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Quarterly Activities Report/Appendix 4C Cashflow Statement
- Peter Mac Testing Validates AlgoraeOS v2
- Updated - NSW Health Public Hospital Supply Contract
- Algorae Awarded NSW Health Public Hospital Supply Contract
- Algorae Expands AI Drug Combination Pipeline
Later from Algorae Pharmaceuticals
- Appendix 4E and 2026 Annual Report
- Notification of cessation of securities - 1AI
- Date of AGM and Closing Date for Director Nominations
- Change of Director's Interest Notice - DH
- Notice of Annual General Meeting/Proxy Form
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals